Patents by Inventor Douglas Fearon

Douglas Fearon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF CXCR4 SIGNALING IN CANCER IMMUNOTHERAPY
    Publication number: 20180228894
    Abstract: The inventions describes a method for increasing effector T cell accumulation in cancer cell-containing sites of a tumor, comprising administering to a subject in need thereof a pharmaceutically effective amount of an inhibitor of CXCR4 signaling
    Type: Application
    Filed: February 6, 2018
    Publication date: August 16, 2018
    Applicant: Cambridge Enterprise Limited
    Inventor: Douglas Fearon
  • INHIBITION OF CXCR4 SIGNALING IN CANCER IMMUNOTHERAPY
    Publication number: 20150352208
    Abstract: The inventions describes a method for increasing effector T cell accumulation in cancer cell-containing sites of a tumor, comprising administering to a subject in need thereof a pharmaceutically effective amount of an inhibitor of CXCR4 signaling.
    Type: Application
    Filed: August 18, 2015
    Publication date: December 10, 2015
    Inventor: Douglas Fearon
  • INHIBITION OF CXCR4 SIGNALING IN CANCER IMMUNOTHERAPY
    Publication number: 20150216843
    Abstract: The inventions describes a method for increasing effector T cell accumulation in cancer cell-containing sites of a tumor, comprising administering to a subject in need thereof a pharmaceutically effective amount of an inhibitor of CXCR4 signaling.
    Type: Application
    Filed: February 12, 2015
    Publication date: August 6, 2015
    Inventor: Douglas Fearon